# FDA recall D-0806-2018

> **Prescript Pharmaceuticals, Inc.** · Class II · drug recall initiated 2018-04-24.

## Product

Acetaminophen 300 mg with Codeine Phosphate 30 mg tablets, USP, 20-count M-Pak containers, Rx Only. Mnfct for: Aurobindo Pharma USA, Inc., Dayton, NJ 08810. Mnfct by: Aurolife Pharma LLC, Dayton, NJ 08810. Pckgd by PreScript Pharm Inc. Pleasanton, CA 94566. NDC: 13107-059-99 Bar Code 0078-20-2033

## Reason for recall

Labeling: Not Elsewhere Classified:  due to a labeled declaration of; Store at 15¿C to 30¿C (59¿F to 86¿F) which differs from the original manufacturer declaration of; Store at 20¿C to 25¿C (68¿F to 77¿F).

## Distribution

California.

## Key facts

- **Recall number:** D-0806-2018
- **Recalling firm:** Prescript Pharmaceuticals, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2018-04-24
- **Report date:** 2018-05-23
- **Termination date:** 2019-01-23

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Pleasanton, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0806-2018

## Citation

> AI Analytics. FDA recall D-0806-2018. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-0806-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*